Article

(2022) Best insights on target molecules for drug design of nCOVID-19 based on pharmacological and peptide-based therapeutics. Health Biotechnology and Biopharma. pp. 62-81.

(2022) Evaluation of ESR, CRP, LDH, CPK, D-Dimer, BS and FBS levels in hospitalized COVID-19 patients with mucormycosis. Health Biotechnology and Biopharma. pp. 43-51.

(2022) Investigation of factors affecting adult erythrocyt sedimentation rate. Health Biotechnology and Biopharma. pp. 45-54.

(2022) Prevalence and impact of coagulation dysfunction in patients with COVID-19 in Yazd. Health Biotechnology and Biopharma. pp. 53-61.

(2022) Relationship between blood albumin level and clinical condition of patients with Covid-19 admitted to Shahid Sadoughi hospital in Yazd. Health Biotechnology and Biopharma. pp. 26-32.

(2022) The Role of NRF2/KEAP1 Pathway in Glioblastoma: Pharmacological Implications. Medical Oncology.

(2021) Effects of Galbanic Acid on Proliferation, Migration, and Apoptosis of Glioblastoma Cells Through the PI3K/Akt/MTOR Signaling Pathway. Current molecular pharmacology. pp. 79-87.

(2021) Frequency Distribution of Cutaneous Leishmaniasis in the Central Region of Iran. Turkiye parazitolojii dergisi. pp. 45-48.

(2021) Nanoarchitectures in management of fungal diseases: An overview. Applied Sciences (Switzerland).

(2021) Overview of key molecular and pharmacological targets for diabetes and associated diseases. Life Sciences.

(2021) Targeting LIN28: A new hope in prostate cancer theranostics. Future Oncology. pp. 3873-3880.

(2021) TdT Negative Lymphoblastic Lymphoma: A Case Report. Iranian Journal of Blood and Cancer. pp. 140-143.

(2021) An overview of vaccine development for COVID-19. Therapeutic Delivery. pp. 235-244.